Status:

COMPLETED

Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

Lead Sponsor:

Children's Oncology Group

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Neuroblastoma

Eligibility:

All Genders

Up to 30 years

Brief Summary

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer....

Detailed Description

OBJECTIVES: * To establish telomere length measurement by quantitative polymerase chain reaction (qPCR) as an alternative lengthening of telomeres (ALT) detection method in neuroblastoma (NB). * To d...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Snap-frozen neuroblastoma (NB) tumors collected at diagnosis (Objectives 1 to 3)
  • High-risk stage 3 or 4 NB AND MYCN non-amplified, i.e., exclude stage 4 infants who are not high-risk
  • Up to five high-risk (\> 18 months, unfavorable histology) stage 3/MYCN non-amplified tumors
  • Patients preferably treated on protocol COG-A3973 or similar protocols with myeloablative therapy
  • At least 3 years of follow-up for those with no event (current evidence suggests that ALT+ NBs often relapse late, i.e., 2 years or longer from diagnosis)
  • NB tumor DNA collected at diagnosis (Objectives 2 \& 3)
  • High-risk stage 3 or 4 NB as for Objective 1, except for MYCN status
  • Stage 4 tumors are preferred; may include up to seven high-risk stage 3 tumors with similar distribution of MYCN-amplified and non-amplified tumors
  • Frozen serum from NB patients (Objective 5; 2nd stage of project)
  • Paired serum obtained at diagnosis from patients with ALT+ or ALT- tumors identified in Objective 2
  • PATIENT CHARACTERISTICS:
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

Exclusion

    Key Trial Info

    Start Date :

    January 1 2012

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2016

    Estimated Enrollment :

    99 Patients enrolled

    Trial Details

    Trial ID

    NCT01510600

    Start Date

    January 1 2012

    End Date

    May 1 2016

    Last Update

    May 19 2016

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.